← Back to Search

Entre Herman@s Program for HIV Prevention

N/A

Recruiting

Led By Homero del Pino, PhD, MS

Research Sponsored by Charles Drew University of Medicine and Science

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial aims to reduce HIV incidence among Latino gay men by training siblings to promote PrEP use. Control group will talk about vaccines to prevent other diseases.

Who is the study for?

This trial is for Latino men under 40 who have sex with men, are HIV-negative, haven't used PrEP recently or at all, and are missing certain vaccines. They must be open to discussing healthcare with a sibling and meet specific criteria like not being in a monogamous relationship with an HIV-negative partner.Check my eligibility

What is being tested?

The study compares two approaches: one where siblings encourage their gay brothers to use PrEP (a medication to prevent HIV), and another where they talk about getting vaccinated against COVID, Hepatitis A/B, or MPOX instead.See study design

What are the potential side effects?

Since this trial focuses on behavioral intervention rather than medication side effects aren't the main concern. However, discussions around sensitive health topics could potentially cause emotional discomfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants that get vaccinated

Number of participants that start using PrEP

Secondary outcome measures

Number of participants who increase their willingness to get vaccinated

Number of participants who increase their willingness to use PrEP

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: PrEP PromotionExperimental Treatment1 Intervention

Group II: Vaccine PromotionPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Charles Drew University of Medicine and ScienceLead Sponsor

51 Previous Clinical Trials

6,239 Total Patients Enrolled

St. John's Community HealthUNKNOWN

Homero del Pino, PhD, MSPrincipal InvestigatorCharles Drew University of Medicine and Science

Media Library

Entre Herman@s Clinical Trial Eligibility Overview. Trial Name: NCT05805306 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: PrEP Promotion, Vaccine Promotion

Human Immunodeficiency Virus Infection Clinical Trial 2023: Entre Herman@s Highlights & Side Effects. Trial Name: NCT05805306 — N/A

Entre Herman@s 2023 Treatment Timeline for Medical Study. Trial Name: NCT05805306 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this clinical trial encompass individuals aged thirty and above?

"As specified by the inclusion criteria, only individuals aged between 18 and 39 are eligible for this trial. Conversely, there are 112 trials specifically tailored to minors and 338 studies reserved for geriatric patients."

Answered by AI

How many individuals are contributing to this research effort?

"Affirmative. Per the information sourced on clinicaltrials.gov, this medical trial is actively looking for participants and was first posted to the website on April 15th 2023. Last updated on 4/6/2023, it seeks 248 patients from a single site of recruitment."

Answered by AI

Is the recruitment period of this trial still ongoing?

"Affirmative. Clinicaltrials.gov reveals that this clinical trial is actively recruiting participants, which began on April 15th 2023 and was last updated 6 days later. The study has a requirement of 248 patients from 1 medical centre."

Answered by AI

Is it possible to join the research trial?

"In order to have the opportunity to participate, applicants must be infected with HIV and between 18-39 years of age. There is an overall target recruitment quota of 248 patients for this trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Entre Herman@s: Promoting Health Among Latino MSM

Homero del Pino 2023. "Entre Herman@s: Promoting Health Among Latino MSM". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05805306.